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. In recent years, atypical femoral fractures(AFFs)have been reported in patients on long-term bisphosphonate therapy 2)−6)
. AFFs has been defined as subtrochanteric or femoral shaft fractures after minimal or no trauma. The revised case definition of AFFs was reported by a task force of the American Society of Bone and Mineral Research (ASBMR) 7) . The trends in the incidence of subtrochanteric fracture and bisphosphonate use in the US elderly population from 1996 to 2007 have been reported, and it was found that the rate of subtrochanteric hip fracture and bisphosphonate use increased in parallel 8) . To determine whether prolonged bisphosphonate therapy is associated with an increased risk of subtrochanteric or femoral shaft fracture, a population-based, nested case-control study was conducted in Canada 9) .
And it was reported that treatment with a bisphosphonate for more than 5 years was associated with an increased risk of subtrochanteric or femoral shaft fractures among older women. Although several case reports of AFFs in patients on long-term bisphosphonate therapy have also been reported in Japan 10)−12)
, the precise incidence rate, the trend, and the causal relationship with bisphosphonates remains uncertain.
Safety studies using claims databases is an appealing approach to the causal relationship between long-term bisphosphonate use and the incidence of AFFs. Since such analysis has been rarely performed in Japan, a validation study on the definition of AFFs using claim-based database is needed. We aimed to clarify the predictive accuracy to clinically-confirmed AFFs(as suspected AFFs)using claim-based definition. This study was planned based on the method previ-ously reported in the population-based, nested case-control study and the appendix 9)
.
Materials and Methods

Ethics Statement
The protocol of this study was approved by the Ethical Committee of Public Health Research Foundation and was conducted in accordance with the ethical guidelines for epidemiological research by Japanese Ministry of Health, Labor and Welfare. Because of retrospective nature of this study, written informed consent was waived in accordance with the Guidelines for Epidemiological Research Issued by the Ministry of Health, Labor and Welfare.
Study Design and Data Source
We collected anonymized databases from three hospitals cross-sectionally. The hospitals have orthopedic departments that perform bone fracture surgery and their electronic medical record databases of the diagnosis procedure combination (DPC)are available. The profiles of the institutes, including numbers of beds and patients, are shown in Table 1 .
Study Subjects and Claims-based Definitions
The study subjects were patients who have International Classification of Diseases, 10th Edition(ICD-10)codes of the 6 types of fractures between April 1, 2010 and October 31, 2012 in the claims databases. Six types of fractures were consisted with fracture of thoracic vertebra (ICD-10: S22.0), multiple fractures of thoracic spine(S22.1), fracture of sternum(S22.2), fracture of one rib(S22.3), multiple fractures of ribs (S22.4), fracture of lumbar vertebra (S32.0), . The influence of sex, age, the presence or absence of accident and trauma, and osteoporosis and malignancy(ICD-10: C00 to C97, D00 to D09)on the diagnostic accuracy was also explored by subgroup analysis.
Outcome
The primary outcome was clinically confirmed suspected AFFs, defined by physician of each hospital with discharge records, operation records, or radiographic images selected from the electronic medical record databases. The data for the primary outcome was collected on February 1, 2010 to October 31, 2012.
Statistical Analysis
The positive predictive value(PPV), sensitivity, and the specificity and their exact 95％ confidence interval(CI)of the claims-based candidate patients for identifying clinically confirmed(suspected)AFFs were calculated.
Results
The number of six types of fracture was 2535 in the three hospitals. Major fracture types(over 10％)were fracture of lumbar vertebra(S32.0): 607 cases(23.9％), fracture of one rib(S22.3): 388 cases(15.3％), fracture of head and neck of femur(S72.0): 300 cases(11.8％). Nine cases with subtrochanteric fracture and 23 cases with femoral shaft fracture were identified based on ICD codes in the claims databases( subtrochanteric fracture and femoral shaft fracture was 11 and 28, respectively(including both fractures: 1 case). Break down information in the cases with subtrochanteric fracture and femoral shaft fracture were show in Table 3. The sensitivity, specificity, and the 95％ CI of subtrochanteric fracture in the claims databases compared to clinically confirmed subtrochanteric fracture are shown in Table 4 . The sensitivity was 81.8％(95％ CI: 48.2-97.7％), and the specificity was 100.0％(95％ CI: 99.9-100.0％).
In femoral shaft fracture (Table 5) , the sensitivity was 82.1％(95％ CI: 63.1-93.9％), and the specificity was 100.0％(95％ CI: 99.9-100.0％).
Subgroup analyses divided by age, sex, fracture site, and co-morbidity in patients with subtrochanteric fracture and femoral shaft fracture are shown in Table 6 and Table 7 , respectively. The specificities and PPV for both fractures in the claims databases were 100％ to clinically-confirmed suspected AFFs. The sensi-tivities in patients over the age of 50 years with a single fracture site were relatively higher than in the other subgroups.
Discussion
This validation study showed that the predictive accuracy of suspected AFFs by clinicallydefinition and candidate fracture defined by two ICD-10 codes, subtrochanteric fracture(S72.2) and fracture of shaft of femur(S72.3), in the claims databases is high in relation to clinicallyconfirmed suspected AFFs.
Epidemiological data indicates that subtrochanteric and femoral shaft fractures account for approximately 10％ of all hip and femoral fractures in the elderly 13) . Of these, around 15-30％ are atypical, and AFFs thus probably account for only about 4 to 14％ of all fracture of the femure 14) . In the present study, a total of 39 clinically-confirmed suspected AFFs were identified in the claims databases from the three hospitals. High sensitivities and specificities were . Subtrochanteric and femoral shaft fractures may be strongly affected by the background factors such as age, sex, and co-morbidity affect sensitivity. Therefore, it was thought that an appropriate combination of these factors may increase the sensitivity.
There are a few previous data about the incidence of subtrochanteric and femoral shaft fractures and the associations with bisphosphonates from a safety study using large-scale administrative databases in Japan. A major advantage of such a study is its large sample size which allows for in-depth investigations. Given the high sensitivities and specificities shown in this study, the National Receipt Database (NRDB)is expected to be useful to clarify the precise incidence rates of AFFs and the causal relationship with osteoporosis treatments including bisphosphonate in the Japanese population.
There are three limitations of this study. First is the small number of clinically-confirmed suspected AFFs patients. However, it was reported that the incidence of actual AFFs was very low compare to the incidence of hip fracture 14) . Second, we did not obtain the reason of fracture incidence(by traumatic or nontraumatic). Therefore traumatic fracture may be included. But higher sensitivity, specificity and PPV were also observed in the subgroup of age B50 years, the bias to this result may be relatively small. Third, suspected AFFs in this study do not exactly match to definition of AFFs by ASBMR task force. Additional study may be needed to clarify the relationship between clinically-defined AFFs and gold standards of AFFs defined by the methods of ASBMR.
In conclusion, the claims-based definitions of suspected AFFs is accurate, indicating the value of pharmacoepidemiological studies using the NRDB.
